SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Clown-Free Zone... sorry, no clowns allowed
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Gut Trader who wrote (163304)5/1/2002 5:26:12 PM
From: reaper  Read Replies (1) of 436258
 
GT -- not really. just means that there is TONS of stuff coming off patent with no real "killer apps" coming up behind. all the talk about too-expensive drugs is going to be ramping down by next year as the generics take a gigantic chunk out of the hide of big pharma.

people had been hoping that some of the DNA mapping would be starting to provide something tangible by now in terms of NCEs/biologicals getting into the clinic. but so far that hasn't happened. so the earnings bases of all of these drug companies are going to be gutted in the next 3 years. they are wasting assets at this point, unless those $billions they direct at R&D every year starts coming up with something interesting.

Cheers
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News